EP
RETA

Edgestream Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Edgestream Partners’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,671
Closed -$374K – 1025
2023
Q2 		$374K Sell
3,671
-8,679
-70% -$885K 0.03% 592
2023
Q1 		$1.12M Sell
12,350
-27,488
-69% -$2.5M 0.12% 275
2022
Q4 		$1.51M Sell
39,838
-41,922
-51% -$1.59M 0.17% 196
2022
Q3 		$2.06M Buy
+81,760
New +$2.06M 0.16% 190